SNUH to Expand K-Bio Global Presence at BIO USA 2026

Seoul National University Hospital (SNUH) will operate its first independent booth at the BIO International Convention 2026 in San Diego from June 22-25. The hospital plans to showcase five bio startups and the Korea Health Data Platform (KHDP) to attract global investors and research partners, according to an official SNUH announcement.

Which Korean bio startups are scaling globally?

SNUH is using the San Diego event to push five specific startups into the international market. Two of these companies, MEDIARK and HTnB, were selected via the “Global Bio Scale-Up Enterprise Advancement & Transformation” (G.R.E.A.T) project. MEDIARK focuses on gene therapies using metal-organic framework (MOF)-based nucleic acid delivery, while HTnB develops dental biomaterials and radioprotective agents.

The hospital’s own affiliated startups are also featured. RSREHAB is presenting medical devices for dysphagia treatment, and Idea2Market is showcasing biosignal-based digital healthcare tech. CENYXBIOTECH is promoting therapeutics based on its nanozyme platform, according to the hospital’s project details.

Did you know? The G.R.E.A.T project specifically targets bio companies that have been established for five years or less, ensuring that only early-stage, high-growth potential firms receive this level of global exposure.

How does the G.R.E.A.T project fund bio-innovation?

The G.R.E.A.T project operates with a total budget of KRW 12.6 billion. Supported by the National Research Foundation of Korea and the Ministry of Science and ICT, the initiative began in 2024. It’s designed to select 14 companies over a six-year period to provide technology development and commercialization support.

This funding model shifts the hospital’s role. President Nam-Jong Paik stated that SNUH’s research must create a “virtuous cycle” between academia, industry, and hospitals. Instead of just treating patients, the hospital’s goal is to act as an innovation platform that connects local tech to global investment.

What is the Korea Health Data Platform (KHDP)?

The Korea Health Data Platform (KHDP) is a global research platform designed for the analysis and utilization of digital health data. SNUH is developing this system following its 2024 designation as Korea’s first National Strategic Technology Specialized Research Institute by the Ministry of Health and Welfare.

According to Executive Vice President for Research Sung-Keun Kwon, the standalone booth at BIO USA serves as the primary vehicle to introduce these research capabilities to the world. The hospital intends to use KHDP to secure joint research agreements with overseas institutions and industry partners.

Pro Tip: For biotech investors, the integration of clinical data platforms like KHDP reduces the “valley of death” by providing validated real-world evidence (RWE) faster than traditional trial methods.

What follows the BIO USA 2026 event?

Collaboration efforts continue on June 26 with a dedicated event in the U.S. jointly hosted by SNUH, Shinhan Financial Group, and the Korea Technology Finance Corporation. This follow-up includes investment presentations from venture companies and panel discussions with industry experts.

🎞 #ChatsWIthChaudhrey S7E22 BIO International Convention 2026 Preview w Solvias CSO Daniel Galbraith

A key component of this event is an educational seminar linked with Stanford Biodesign. The session focuses on a specific innovation methodology: identifying “unmet needs” first, rather than starting with the technology itself. This approach aims to help Korean firms design more precise strategies for entering the U.S. healthcare market.

Frequently Asked Questions

What is the main goal of SNUH at BIO USA 2026?

SNUH aims to expand the global presence of “K-Bio” by supporting startups, showcasing the Korea Health Data Platform (KHDP), and attracting international investment.

Which government bodies support the G.R.E.A.T project?

The project is supported by the Ministry of Science and ICT and the National Research Foundation of Korea.

What makes the June 26 event different from the convention?

While the convention is a broad industry gathering, the June 26 event is a targeted collaboration session featuring Stanford Biodesign and financial partners like Shinhan Financial Group.

Want to stay updated on the latest in biotech innovation and K-Bio trends? Subscribe to our newsletter or leave a comment below on which of these startups you’re watching.